CO2 Abatement in the Steel Industry through Carbon Recycle and Electrification by Means of Advanced Polymer Membranes.

The potential of advanced polymer or hybrid polymer membranes to reduce CO2 emissions in steel production was evaluated. For this, a conceptual process design and assessment was performed for a process that is a combination of carbon recycling and electrification of the steel making process. The results indicate a CO2 avoidance of 9%. CO2 emissions were reduced by factor 1.78 when using renewable electricity according to the proposed scheme compared to feeding this renewable electricity to the electrical grid. The CO2 abatement potential of the studied concept is highly dependent on the CO2 conversion in the plasma torch. If CO2 conversion in the plasma torch could be increased from 84.4% to 95.0%, the overall CO2 avoidance could be further increased to 16.5%, which is comparable to the values reported for the top gas recycling blast furnace. In this case, the CO2 emissions reduction achieved when using renewable electricity in the proposed scheme compared to using the same electricity in the electrical grid increases a factor from 1.78 to 3.27.

Lipid status association with 25-hydroxy vitamin D: Cross sectional study of end stage renal disease patients.

BACKGROUND: Some observational studies indicate an association of 25-hydroxy vitamin D (25(OH)D) insufficiency and atherogenic cholesterol concentrations. The aim of this study was to investigate relationship between 25(OH)D concentrations and lipid parameters in end stage renal disease (ESRD) patients, separately for predialysis, hemodialysis and peritoneal dialysis patients. METHODS: We have adjusted 25(OH)D concentrations for seasonal variability with cosinor analysis, and performed all further analysis using these corrected 25(OH)D concentrations. Concentrations of 25(OH)D and the lipid parameters were determined in 214 ESRD patients and 50 control group participants. The analysis included the measurement of 25(OH)D by HPLC, apolipoprotein (Apo) AI, ApoB and Lp(a) by nephelometry, total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C) and triglyceride (TG) by spectrophotometry and manually calculated ApoB/ApoAI and LDL-C/HDL-C ratio. RESULTS: ESRD patients with adjusted 25(OH)D concentrations of 50 nmol/L had significantly higher TC (P = 0.005) and ApoAI (P = 0.049). Significantly higher HDLC (P = 0.011) and ApoAI (P = 0.020) were found in hemodialysis patients with the 25(OH)D concentrations of 50 nmol/L. The other analyzed lipid parameters differed significantly between predialysis, hemodialysis and peritoneal dialysis patients with 25(OH)D concentrations of < 50 nmol/L. CONCLUSIONS: Our study indicate the significant relationship between 25(OH)D repletion and optimal concentrations of lipid parameters in ESRD patients. Further research is necessary to explain whether joint evaluation of vitamin D status and lipid abnormalities could improve cardiovascular outcome in ESRD patients.

Nutrition and lifestyle in relation to bone health and body weight in Croatian postmenopausal women.

The objective was to investigate the association of nutrients and lifestyle modifiers with bone mineral density (BMD) and weight and/or body mass index (BMI) in 120 healthy Croatian postmenopausal women. The hip and spine BMD was assessed by Lunar Prodigy (GE Medical Systems). Nutrient assessment from 3-day records was analyzed using the US Department of Agriculture Food Composition Tables and the Croatian National Institute of Public Health database. Subjects were asked to record the consumption of alcohol, coffee, tea and mineral waters, the amount of salt added to foods and smoking habits, as well as involvement in recreational activities, walking and heavy housework. Spot urine samples were analyzed for calcium, magnesium, sodium, potassium and zinc and were normalized by creatinine. Alcohol showed statistically significant positive association with femur and spine BMD and its consumption was higher in subjects without osteoporosis. Urinary sodium/creatinine was significantly positively associated with femoral neck and trochanter BMD, while urinary calcium/creatinine was significantly negatively associated with trochanter, total femur and spine BMD. Consumption of mineral waters was inversely associated with weight/BMI and so were dietary fiber and magnesium. In conclusion, moderate alcohol consumption and urinary sodium were positively associated while urinary calcium was negatively associated with either hip and/or spine BMD. Mineral waters, higher fiber and magnesium intake were beneficial for weight/BMI in this population of apparently healthy Croatian women.

Countertransference in the therapy of suicidal patients - an important part of integrative treatment.

One of the central issues in the psychotherapy of suicidal patients is the countertransference. Key concepts in countertransference include projective identification, role-responsiveness and countertransference enactment. It is important to recognize that countertransference can be effective in understanding the emotional intensity of the suicidal person's internal world. There is a significant relationship between treatment outcome and the different countertransference feelings among the therapists. In this paper we have illustrated important factors for understanding psychiatrist's countertransference reactions when working with suicidal patients.

Anti-annexin A5 antibodies and 25-hydroxy-cholecalciferol in female patients with primary antiphospholipid syndrome.

Vascular antiphospholipid syndrome (VAPS) and obstetric (OAPS) are different entities because some patients only develop thrombosis (without recurrent pregnancy losses) and vice versa. Only two articles have reported that low 25-hydroxy-cholecalciferol (vitamin D3, VD3) levels were not correlated with the presence of conventional antiphospholipid antibodies (aPL Abs: anticardiolipin (aCL), anti-beta2glycoprotein I (aß2gpI), and lupus anticoagulant (LA)), but no article analyzed the association of VD3 and anti-annexin A5 (aanxA5) Abs. The aim of our study was to investigate the association between VD3, multiple positivity of conventional aPL and aanxA5 Abs levels only in female OAPS vs. VAPS. Our study included 62 consecutive female PAPS patients. Concentrations of Abs were measured by ELISA, while VD3 levels were determined by immunochemiluminescence. Only 10/62 (16.13%) had sufficient (≥ 30 ng/ml) VD3 levels, while 48/62 (77.42%) and 4/62 (6.45%) had insufficiency and VD3 deficiency, respectively. Statistically significant VD3 deficiency was noticed in VAPS (vs. OAPS, P = 0.013). A negative correlation between VD3 levels and the age of patients was noticed (r = - 0.493, P = 0.032) only in VAPS subgroup. Multiple positivity of aPL and aanxA5 Abs was not associated with VD3 deficiency. Newly emerging aPL Abs, such as aanxA5 Abs, or their combinations with classical aPL Abs are not associated with VD3 deficiency in neither OAPS nor VAPS patients. Due to its immunomodulatory roles in B-Ly homeostasis, supplementation with VD3 should be considered in APS, at least in subgroup with severe form of the disease, i.e., VAPS.

Metabolic syndrome and combat post-traumatic stress disorder intensity: preliminary findings.

BACKGROUND: Post-traumatic stress disorder (PTSD) has been associated with co-morbidity of many major mental and somatic disorders as well as with premature mortality. OBJECTIVE: The objective of this study was to examine the relationship between combat-related PTSD, metabolic syndrome and its components as well as between PTSD severity and metabolic syndrome. METHODS: Metabolic syndrome and its components were investigated in 100 male war veterans with combat PTSD and in 79 males who needed medical attention in a family medicine dispensary. RESULTS: Metabolic syndrome according to the modified NCEP: ATP III criteria was found in 35% of our PTSD patients. Metabolic syndrome and intensity of PTSD were significantly related. Metabolic syndrome was identified in 66.7% of the war veterans with high intensity of PTSD in comparison to 23.3% of the veterans with low intensity PTSD. CONCLUSIONS: Prevalence of metabolic syndrome and its components is elevated in war veterans with PTSD. PTSD is a multi-systemic disorder and treatment of war veterans with PTSD should address co-morbid somatic disorders including metabolic syndrome in addition to the clinical features of PTSD.

Mental disorders and metabolic syndrome: a fatamorgana or warning reality?

BACKGROUND: There has been a growing interest in the effect that comorbid mental and somatic disorders may have on each other. Metabolic syndrome is an important risk factor for the development of diabetes mellitus, cardiovascular disease and premature mortality. OBJECTIVES: To examine the association between various mental disorders (schizophrenia, schizoaffective disorder, bipolar disorder, depression, post-traumatic stress disorder and other mental disorders) and metabolic syndrome and discuss the possible pathophysiologic mechanisms that may link specific mental disorders and metabolic syndrome. METHOD: A MEDLINE search, citing articles from 1966 onward, supplemented by a review of bibliographies, was conducted to identify relevant studies. Criteria used to identify studies included (1) English language, (2) published studies with original data in peer-reviewed journals. RESULTS: Clinical investigation of the metabolic syndrome in patients with mental disorders, except schizophrenia, has been surprisingly scarce. Metabolic syndrome was reported in 19-63% of schizophrenic patients, in 42.4% of patients with schizo-affective disorder, in 24.6-50% of bipolar patients, in 12-36% of the patients with recurrent depression and in 31.9-35% of patients with combat posttraumatic stress disorder. CONCLUSION: Metabolic syndrome can contribute to significant morbidity and premature mortality and should be accounted for in the treatment of mental disorders. No definite or reliable insight into the pathophysiological link between metabolic syndrome and mental disorders is available.

Metabolic syndrome, somatic and psychiatric comorbidity in war veterans with post-traumatic stress disorder: Preliminary findings.

BACKGROUND: There has been a growing interest in the effect that co-morbid mental and somatic disorders may have on each other. Post-traumatic stress disorders (PTSD) have been associated with comorbidity of many major somatic and mental disorders as well as with premature mortality. OBJECTIVE: The objective of this study was to examine the relationship between combat-related PTSD, metabolic syndrome and comorbid psychiatric and somatic diagnoses. METHOD: Metabolic syndrome and its components as well as comorbid somatic and mental disorders were analysed in 47 male war veterans with combat PTSD. RESULTS: Only 4.25% of our patients were without any comorbid somatic and mental disorders, metabolic syndrome or any of its components. Other psychiatric or medical condition was diagnosed in 76.6 % of the PTSD patients. Metabolic syndrome according NCEP: ATP III was found in 31.9% of our PTSD patients. CONCLUSIONS: PTSD is multisystemic mental and somatic disorder. The treatment of war veterans with PTSD should address comorbid other mental and somatic disorders including metabolic syndrome as well as the clinical features of PTSD.

Sodium and calcium intakes and bone mass in rats revisited.

OBJECTIVE: High sodium intake accompanied by insufficient dietary calcium may have detrimental effects on bone mass. Our study evaluated the effects of increased sodium and decreased calcium intakes on bone mineral density (BMD) and bone mineral content (BMC) in rats. METHODS: Four-month-old female Wistar rats were given deionized water or 1.8% solution of sodium chloride in deionized water and fed normal (1.2%) or marginal (0.33%) calcium in the diet for 2 mo. At the end of the experiment, BMD and BMC of the whole body and urinary sodium and calcium excretion were evaluated. All rats were killed and right femurs were removed to assess dry and ash weights. Two-way analysis of variance was used to evaluate effect of salt intake and effect of dietary calcium on these parameters. RESULTS: Salt-loaded animals had greater water consumption during the entire 2-mo period and significantly lower body weight from week 5 of the experiment. High salt intake increased urine volume and urinary excretion of sodium and calcium. Urinary calcium was about five times higher in salt-loaded animals than in rats on deionized water irrespective of dietary calcium content. Calcium in diet itself had no significant effect on these parameters. High salt intake slightly, but not significantly, decreased BMD, BMC, and femur weights. Lower calcium in diet significantly decreased BMD, and its effect on femur ash weight almost reached a level of significance. CONCLUSION: We confirmed the benefit of adequate calcium intake to BMD. Under our experimental condition, high salt intake in rats for 2 mo had no statistically significant effect on femur weights, BMD, or BMC even with marginal calcium in the diet.

[Effects of sodium chloride on bone health]. / Utjecaj natrijeva klorida na kost.

This paper discusses the physiology of sodium effects on calcium metabolism and possible implications of increased salt intake on bone remodelling and bone mass. Osteoporosis is an increasing public health problem affecting more than 200 million of women around the world. The major complications of osteoporosis are fractures, which are frequently associated with high morbidity and mortality. A number of clinical, epidemiological and experimental studies aim at identifying lifestyle factors that may improve bone mass and prevent bone loss. Different nutrients are proposed to play a role in bone development during growth and in the maintenance of bone mass thereafter. However, the importance of sodium intake for bone health has not been elucidated. It is well known that high dietary sodium intake decreases renal calcium reabsorption, which in turn leads to a greater urinary calcium excretion. This effect has been demonstrated in studies in humans of all ages as well as in experimental animals. It is not clear to what extent sodium-induced calcium loss is compensated for by increased intestinal calcium absorption. It is suspected that, if not fully compensated, sustained hypercalciuria due to increased sodium intake may diminish bone mass. Postmenopausal women showed that increased dietary salt may indeed augment bone resorption. Sodium effects on bone mass in various studies are inconsistent and there is still no evidence that increased salt intake is a risk factor in the aetiology of osteoporosis A randomized longitudinal study of different sodium intake in two groups of subject could clarify the role of sodium in bone mass.

Combined early treatment with chelating agents DMSA and CaDTPA in acute oral cadmium exposure.

The influence of chelating agents: meso-2,3-dimercaptosuccinic acid (DMSA); calcium trisodium diethylenetriaminepentaacetate (CaDTPA) and their combination on mobilisation of cadmium (Cd) was compared in female albino rats. After oral Cd administration chelators were applied either orally (DMSA) or intraperitoneally (CaDTPA) at various short time intervals after Cd. Three experiments were carried out with four treatment groups in each: 1) Cd (control); 2) Cd+DMSA; 3) Cd+CaDTPA; 4) Cd+DMSA+CaDTPA. Time intervals for chelator treatment after Cd administration were: immediate application in the first, half an hour in the second and one hour in the third experiment. At the end of each experiment cadmium was analysed in kidney and liver. Additionally in experiment 3 essential elements (Fe, Cu, Zn) were also determined in the same organs. In experiment 2 the effect of the treatment on urinary elimination of cadmium, copper and zinc were analysed. Results showed that the efficiency of Cd removal from the body (kidneys and liver) is lower when the time between Cd and chelating agents administration is longer. The two chelators differ in efficiency in mobilizing Cd, with DMSA being more efficient than CaDTPA. The combined therapy with the two chelators gave generally better results. It seems that DMSA which is given orally after oral Cd administration removes this element very efficiently from the gastrointestinal tract. CaDTPA, however, which is given parenterally removes absorbed Cd less efficiently, Organs are not significantly depleted in iron and copper after chelation treatment. Only zinc concentration was, however, significantly lower in the liver and higher in kidneys only after CaDTPA and combined DMSA+CaDTPA chelation.

The effect of dietary supplementation with calcium salts on skeletal calcium in suckling rats.

This study aimed at identifying a calcium compound which could serve as an effective and safe dietary supplement in suckling rats over the period of intense growth and development. The main objective was to assess the effect of additional calcium intake on skeletal calcium in suckling pups. Suckling Wistar rats were fed using a pipettor with one of the following calcium salts from day 6 to 14 after the birth: gluconate, hydrogenphosphate, carbonate (each suspended in cow's milk), or chloride (in demineralized water). Control rats received only cow's milk. Calcium in the carcass (body without organs and skin) was analysed by atomic absorption spectrometry. The only effective dietary supplement that produced no risk for the suckling pups' growth was calcium hydrogenphosphate in cow's milk in the total amount of 340 mg. That dose increased the daily calcium intake 3 to 4 times compared to non-supplemented controls, increasing carcass calcium content by about 16 per cent. Other calcium compounds were either inefficient (carbonate) or had adverse effects on pups' growth (chloride and gluconate).

Ascorbic acid supplementation does not improve efficacy of meso-dimercaptosuccinic acid treatment in lead-exposed suckling rats.

It was suggested that ascorbic acid as a natural chelating agent can influence lead toxicokinetics and improve chelating properties of dimercaptosuccinic acid (DMSA) in adult rats. In this paper potential benefits of ascorbic acid supplementation, alone or combined with DMSA, in decreasing lead retention in suckling rats were evaluated. Such data in young mammals are not available. L-Ascorbic acid (daily dose 650 mg/kg b.wt.) and/or DMSA (daily dose 91 mg/kg b.wt.) were administered orally to suckling Wistar rats either during ongoing 8-day oral lead exposure (as acetate; daily dose 2 mg lead/kg b.wt.) or after 3-day lead exposure (total dose 12 mg lead/kg b.wt.). Lead concentrations were analysed in the carcass (skeleton), liver, kidneys and brain by atomic absorption spectrometry. By ascorbic acid supplementation lead retention was not reduced under either lead exposure condition. Lead concentration was even increased in the carcass. Treatment with DMSA under both exposure conditions significantly reduced lead in all analysed tissues. Combined treatment with ascorbic acid and DMSA during ongoing lead exposure was substantially less effective than DMSA treatment alone, and did not affect DMSA efficacy when administered after lead exposure. It was concluded that ascorbic acid administered either during or after lead exposure in suckling rats has no beneficial effect on either lead retention or DMSA chelation effectiveness.